About
A physician-scientist with over two decades of drug discovery and development experience, David previously held senior R&D leadership roles at Merck and Eli Lilly and served as chief scientific officer at several biotech companies. He began his career as a faculty member at Harvard Medical School.
Invests in
BiotechMedical Devices
Experience
- Third Rock VenturesVenture Partnercurrent2025 — present
- Variant Bio*, Eccogene*, Six Peaks, Avilar, Novo Centre for Metabolic ResearchDirector*; SAB Member; Senior Advisorcurrent2025 — presentSeattle, Boston, Copenhagen
- Variant Bio, POXEL; Sigilon TherapeuticsChief Scientific Officer2018 — 2025Greater Boston Area, Seattle and Lyon, France
- Eli Lilly and CompanyVice President and Therapeutic Area R&D Leader2005 — 2018Indianapolis, IN; Cambridge, MA
- MerckVice President Metabolic Disorders1995 — 2005New Jersey
- Harvard Medical SchoolAssistant Professor1990 — 1995
Education
- Brown UniversityBS, Biology
- Harvard Medical SchoolFellowship in Endocrinology; Postdoctoral Research (Flier laboratory)
- University of CincinnatiDoctor of Medicine (MD)
Skills & more
IND5Clinical Development26Clinical Trials27Basic ResearchLicensing AgreementsEndocrinology45Drug Development54Neuroscience1Cardiovascular Disease8Immunology4Licensing6Pharmacology9
+12 more
Molecular BiologyUrologyOncologyDiabetesType 2 DiabetesMetabolic SyndromeVaccinesClinical ResearchMetabolismCTMSPharmaceutical IndustryBiotechnologyLanguages French
From David's professional profile.
Same school
Also attended Brown University301
Alexis AbramsPartner, General Counsel at Felicis VenturesJohn KimInvestor Relations at General CatalystAli Fisher SweetInvestor at Index VenturesMark GoldbergInvestor at Index VenturesKarim FarisInvestor at GV (Google Ventures)Dylan FieldCo-founder and CEO of Figma
.png)
+ 295 more
Also attended Harvard Medical School113
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 107 more
Also attended University of Cincinnati27
Jim GoetzPartner at Sequoia CapitalCandice BrackeenGeneral Partner at Lightship CapitalAlbert WangSenior Director at Qualcomm VenturesNeil ChatterjeeAdvisor, Former Chairman, Federal Energy Regulatory Commission (FERC) at Overture ClimateBrian SmithManaging Director at S3 VenturesDave SchallerPartner at Delta-v Capital
+ 21 more
Shared employers
Also worked at Eli Lilly and Company69
Jesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios CapitalKjersti FrognerInvestor at Almi InvestMilla KoistinahoPartner, Innovestor Life Science at Innovestor Ventures
+ 63 more
Also worked at Merck90
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechAndrea van ElsasInvestor at Third Rock VenturesDavid KaufmanInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures
+ 84 more
Also worked at Harvard Medical School116
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux CapitalZach CollinsPartner at Mission Biocapital
+ 110 more
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures